{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:22:56Z","timestamp":1793283776671,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Amgen Mexico"},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic>Summary<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>Epidemiologic and economic data regarding osteoporotic fractures in Mexico is scarce and mostly outdated. Through a model, we estimated the incidence and costs of osteoporotic fractures in adults\u2009\u2265\u200950\u00a0years old in Mexico during the year 2023. Results showed that these events are both frequent and costly, leading to a considerable economic impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Osteoporosis and its fractures impose a high clinical and economic burden. The objective of this analysis was to estimate the frequency and costs owing to incident fragility fractures (FFs) during the year 2023 in Mexico.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is an incidence-based cost-of-illness study. The target population is adults\u2009\u2265\u200950\u00a0years old sustaining a fracture related to osteoporosis (caused by a fall on the same level). The model estimates the costs and productivity losses associated with their treatment within 1\u00a0year post-fracture. National epidemiologic databases supplemented with information, derived from literature when appropriate, were used to estimate the frequency of new FFs during 2023 in the study population. Resource use included surgical and non-surgical inpatient or ambulatory care the patients received immediately after fracture plus the outpatient physiotherapy post-discharge and the eventual follow-up with a specialist who may prescribe pharmacotherapy. Sick days taken in employed patients were estimated from the literature. Local unitary costs of services and drugs for both public and private settings as well as average income in those occupied were applied. All costs are reported in Mexican pesos (MXN) from 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The model estimated a total of 229,239 FFs, among which 63% were classified as a major osteoporotic fracture, including 53,842 and 41,459 fractures located at the hip and vertebral, respectively. The total costs were estimated at 15,593 million MXN; most of them (75.2%) were attributable to acute-phase care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Fragility fractures represent a serious health problem for Mexico. Better preventive\/therapeutic strategies may help to mitigate their significant financial toll.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11657-024-01468-2","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T22:03:39Z","timestamp":1730930619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Estimated frequency and economic burden of incident fragility fractures during 2023 in Mexico"],"prefix":"10.1007","volume":"19","author":[{"given":"Fernando","family":"Carlos-Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Antonio","family":"Guzm\u00e1n-Caniupan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Camacho-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Aubry de Maraumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noe","family":"Soria-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"1","key":"1468_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/bmb\/ldaa005","volume":"133","author":"MA Clynes","year":"2020","unstructured":"Clynes MA, Harvey NC, Curtis EM, Fuggle NR, Dennison EM, Cooper C (2020) The epidemiology of osteoporosis. Br Med Bull 133(1):105\u2013117. https:\/\/doi.org\/10.1093\/bmb\/ldaa005","journal-title":"Br Med Bull"},{"issue":"1","key":"1468_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","volume":"15","author":"F Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m F, Karlsson L, Orts\u00e4ter G et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15(1):59. https:\/\/doi.org\/10.1007\/s11657-020-0706-y","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L et al (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16(1):609. https:\/\/doi.org\/10.1186\/s13018-021-02772-0","journal-title":"J Orthop Surg Res"},{"issue":"2","key":"1468_CR4","first-page":"183","volume":"65","author":"P Clark","year":"2013","unstructured":"Clark P, Tamayo JA, Cisneros F, Rivera FC, Vald\u00e9s M (2013) Epidemiology of osteoporosis in Mexico. Present and future directions. Rev Invest Clin 65(2):183\u201391","journal-title":"Rev Invest Clin"},{"issue":"2","key":"1468_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ogc.2008.03.007","volume":"35","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM (2008) Prevention and treatment of postmenopausal osteoporosis. Obstet Gynecol Clin North Am 35(2):301\u201315. https:\/\/doi.org\/10.1016\/j.ogc.2008.03.007","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"1468_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC et al (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16(1):82. https:\/\/doi.org\/10.1007\/s11657-020-00871-9","journal-title":"Arch Osteoporos"},{"issue":"7","key":"1468_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1080\/13696998.2019.1590843","volume":"22","author":"R Aziziyeh","year":"2019","unstructured":"Aziziyeh R, Amin M, Habib M et al (2019) The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina. J Med Econ 22(7):638\u2013644. https:\/\/doi.org\/10.1080\/13696998.2019.1590843","journal-title":"J Med Econ"},{"key":"1468_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.34171\/mjiri.34.154","volume":"34","author":"A RashkiKemmak","year":"2020","unstructured":"RashkiKemmak A, Rezapour A, Jahangiri R, Nikjoo S, Farabi H, Soleimanpour S (2020) Economic burden of osteoporosis in the world: a systematic review. Med J Islam Repub Iran 34:154. https:\/\/doi.org\/10.34171\/mjiri.34.154","journal-title":"Med J Islam Repub Iran"},{"issue":"9","key":"1468_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10192","volume":"3","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki EM, Ortendahl JD, Vanderpuye-Orgle J et al (2019) Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States. JBMR Plus 3(9):e10192. https:\/\/doi.org\/10.1002\/jbm4.10192","journal-title":"JBMR Plus"},{"key":"1468_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11657-013-0125-4","volume":"8","author":"F Carlos","year":"2013","unstructured":"Carlos F, Clark P, Galindo-Su\u00e1rez RM, Chico-Barba LG (2013) Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico. Arch Osteoporos 8:125. https:\/\/doi.org\/10.1007\/s11657-013-0125-4","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1468_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","volume":"77","author":"R Tarricone","year":"2006","unstructured":"Tarricone R (2006) Cost-of-illness analysis. What room in health economics? Health Policy 77(1):51\u201363. https:\/\/doi.org\/10.1016\/j.healthpol.2005.07.016","journal-title":"Health Policy"},{"issue":"5","key":"1468_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s001980170112","volume":"12","author":"JA Kanis","year":"2001","unstructured":"Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A (2001) The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 12(5):417\u2013427. https:\/\/doi.org\/10.1007\/s001980170112","journal-title":"Osteoporos Int"},{"issue":"3","key":"1468_CR13","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00198-021-06152-6","volume":"33","author":"C Muschitz","year":"2022","unstructured":"Muschitz C, Hummer M, Grillari J et al (2022) Epidemiology and economic burden of fragility fractures in Austria. Osteoporos Int 33(3):637\u2013647. https:\/\/doi.org\/10.1007\/s00198-021-06152-6","journal-title":"Osteoporos Int"},{"key":"1468_CR14","unstructured":"World Health Organization. International statistical classification of diseases and related health problems. - 10th revision, Fifth edn, 2016. 3"},{"key":"1468_CR15","unstructured":"Consejo Nacional de Poblaci\u00f3n (2018) Proyecciones de la Poblaci\u00f3n de M\u00e9xico y de las Entidades Federativas, 2016\u20132050: Poblaci\u00f3n a mitad de a\u00f1o, Rep\u00fablica Mexicana, a\u00f1o 2023. https:\/\/datos.gob.mx\/busca\/dataset\/proyecciones-de-la-poblacion-de-mexico-y-de-las-entidades-federativas-2016-2050\/resource\/353817d4-ac9d-4709-bbd9-52936fe0423f. Accessed 27 May 2023"},{"key":"1468_CR16","unstructured":"Secretar\u00eda de Salud \/ Direcci\u00f3n General de Informaci\u00f3n en Salud \/ Sistema Nacional de Informaci\u00f3n en Salud. Cubos Din\u00e1micos. \u00daltima modificaci\u00f3n: martes 11 de octubre de 2022. http:\/\/www.dgis.salud.gob.mx\/contenidos\/basesdedatos\/BD_Cubos_gobmx.html. Accessed 27 April 2023"},{"key":"1468_CR17","unstructured":"Instituto Nacional de Acceso a la Informaci\u00f3n. Respuesta a la solicitud 0715000012020 de fecha 20 de abril de 2020. https:\/\/buscador.plataformadetransparencia.org.mx\/en\/web\/guest\/buscadornacional_eu?buscador=0715000012020&coleccion=2 . Accessed 28 Feb 2024"},{"key":"1468_CR18","unstructured":"Instituto Nacional de Estad\u00edstica y Geograf\u00eda (2020) Nota t\u00e9cnica. Estad\u00edsticas de salud en establecimientos particulares 2019. https:\/\/www.inegi.org.mx\/contenidos\/programas\/salud\/doc\/salud_2019_nota_tecnica.pdf. Accessed 23 April 2023"},{"key":"1468_CR19","unstructured":"Instituto Mexicano del Seguro Social (2023) Costos Unitarios por Nivel de Atenci\u00f3n M\u00e9dica y Costos por GRD, actualizados al a\u00f1o 2023 y desagregados. Anexo a la Solicitud No. 330018023003877. https:\/\/buscador.plataformadetransparencia.org.mx\/web\/guest\/buscadornacional?buscador=330018023003877&coleccion=2. Accessed 27 June 2023"},{"key":"1468_CR20","unstructured":"Cat\u00e1logo de Intervenciones, Tratamientos, Servicios Auxiliares de Diagn\u00f3stico y Tarifas para el Intercambio de Servicios 2023. Anexo 1. https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/829148\/Anexo_1._Cat_logo_de_intervenciones__775__IS._DGPLADES_23-05-23_publicar.pdf. Accessed 28 June 2023"},{"key":"1468_CR21","unstructured":"Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n (2022) Tabulador de Cuotas de Recuperaci\u00f3n. https:\/\/www.incmnsz.mx\/2022\/Tabulador_autorizado_2022.PDF. Accessed 28 June 2023"},{"issue":"1","key":"1468_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-021-00926-5","volume":"16","author":"SI Mac\u00edas-Hern\u00e1ndez","year":"2021","unstructured":"Mac\u00edas-Hern\u00e1ndez SI, Degollado-Rodr\u00edguez MM, Maldonado-S\u00e1nchez H et al (2021) The yawning gap between osteoporosis diagnosis and treatment after a fragility fracture in Mexico. Arch Osteoporos 16(1):59. https:\/\/doi.org\/10.1007\/s11657-021-00926-5","journal-title":"Arch Osteoporos"},{"key":"1468_CR23","unstructured":"Programa Anual de Adquisiciones, Arrendamientos, Servicios y Obra P\u00fablica 2023. https:\/\/upcp-compranet.hacienda.gob.mx\/paaasopdashboard\/. Accessed 15 May 2023"},{"key":"1468_CR24","unstructured":"Encuesta Nacional de Ocupaci\u00f3n y Empleo (ENOE), poblaci\u00f3n de 15 a\u00f1os y m\u00e1s de edad (2023) https:\/\/www.inegi.org.mx\/programas\/enoe\/15ymas\/. Accessed 3 July 2023"},{"issue":"8","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-010-1475-z","volume":"22","author":"H Johansson","year":"2011","unstructured":"Johansson H, Clark P, Carlos F, Oden A, McCloskey EV, Kanis JA (2011) Increasing age- and sex-specific rates of hip fracture in Mexico: a survey of the Mexican Institute of Social Security. Osteoporos Int 22(8):2359\u20132364. https:\/\/doi.org\/10.1007\/s00198-010-1475-z","journal-title":"Osteoporos Int"},{"key":"1468_CR26","unstructured":"International Monetary Fund. World Economic Outlook Database, October 2023. Mexico: gross domestic product, current prices, national currency, billions. https:\/\/www.imf.org\/en\/Publications\/WEO\/weo-database\/2023\/October\/weo-report?c=273,&s=NGDP,&sy=2023&ey=2023&ssm=0&scsm=1&scc=0&ssd=1&ssc=0&sic=0&sort=country&ds=.&br=1. Accessed 17 November 2023"},{"key":"1468_CR27","unstructured":"Organisation for Economic Co-operation and Development. OECD Health at a Glance 2023 Country Note: Mexico. https:\/\/www.oecd.org\/mexico\/health-at-a-glance-mexico-EN.pdf. Accessed 17 November 2023"},{"issue":"1","key":"1468_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.15406\/mojor.2019.11.00483","volume":"7","author":"JC Viveros-Garc\u00eda","year":"2021","unstructured":"Viveros-Garc\u00eda JC, Anguiano-Medina A, Arechiga-Mu\u00f1oz E et al (2021) Mexican hip fracture audit (ReMexFC): 2019 annual report. J Lat Am Geriat Med 7(1):20\u201328. https:\/\/doi.org\/10.15406\/mojor.2019.11.00483","journal-title":"J Lat Am Geriat Med"},{"issue":"4","key":"1468_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.35366\/102216","volume":"17","author":"JC Viveros-Garc\u00eda","year":"2021","unstructured":"Viveros-Garc\u00eda JC, Rodr\u00edguez-S\u00e1nchez B, Baldenebro-Lugo LS, Guillermo-Nuncio EA, Nieto-Sandoval HR, V\u00e1zquez-Cantero E (2021) Costos por la demora quir\u00fargica en la fractura de cadera por fragilidad. Orthotips 17(4):195\u2013201. https:\/\/doi.org\/10.35366\/102216","journal-title":"Orthotips"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-024-01468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-024-01468-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-024-01468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T07:11:46Z","timestamp":1734333106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-024-01468-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s11657-024-01468-2","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"FCR has partial time employment with AHS Health Consulting S.A.S. de C.V., which received funding from Amgen Mexico to conduct the study. JAGC has full time employment with and owner of AHS Health Consulting S.A.S. de C.V., which received funding from Amgen Mexico to conduct the study. LMCC is an employee of Amgen Mexico and owns stock in Company. TAdM is an employee of Amgen Mexico and owns stock in Company. NSS is an employee of Amgen Mexico and owns stock in Company.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"109"}}